Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-13

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original ANDA for Nystatin and Triamcinolone Acetonide (Macleods) for topical treatment of fungal skin infections with inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)